Peer Review History: Tirosine Kinase Inhibitors (TKI) Used in the Treatment of Non-Small Cell Lung Cancer (NSCLC) Based on Specific Genetic Alterations

Editor(s):

(1) Prof. Arthur V.M. Kwena, Moi University, Kenya.

Approved by:

(1) Prof. Zoran Todorovic, Professor, School of Medicine, University of Belgrade and University Medical Center “Bezanijska Kosa”, Belgrade, Serbia.

Reviewers:

(1) Basant Farag Abdo, Zagazig University, Egypt.

(2) Kateryna Maliarchuk, National Cancer Institute, Ukraine.

(3) Ni Nyoman Widyastuti Lestari, Parama Sidhi Hospital, Indonesia.

(4) A.V.G.S.Prasad, JNTU, India.

Additional Reviewers:

Additional Reviewers: (Comments received after deadline)

Peer Review History:


Peer review report_1 (Basant Farag Abdo, Egypt) | File 1 | NA


Peer review report_2 (Kateryna Maliarchuk, Ukraine) | File 1 | NA


Peer review report_3 (Ni Nyoman Widyastuti Lestari, Indonesia) | File 1 | NA


Peer review report_4 (A.V.G.S.Prasad, India) | File 1 | File 2


Comment_Academic_Editor | File 1 | NA


Comment_Book_Editor | File 1 | NA